Cavanaugh Sarah has filed 8 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 78000 shares of Celldex Therapeutics, Inc. ($CLDX) on June 05, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | A | Incentive Stock Option (right to buy) | 78000 | $0.00 | 78,000.0000 | 66,383 | 9999.99% | 100.00% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | A | Incentive Stock Option (right to buy) | 78000 | $0.00 | 78,000.0000 | 58,871 | 9999.99% | 100.00% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | M | Common Stock | 10750 | $2.78 | 12,610.0000 | 58,871 | 577.96% | 18.26% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | M | Common Stock | 10103 | $9.02 | 22,713.0000 | 58,871 | 80.12% | 17.16% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | S | Common Stock | 20853 | $33.73 | 1,860.0000 | 58,871 | 91.81% | 35.42% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | M | Incentive Stock Option (Right to Buy) | 10750 | $0.00 | 0.0000 | 58,871 | 100.00% | 18.26% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | M | Incentive Stock Option (Right to Buy) | 10103 | $0.00 | 0.0000 | 58,871 | 100.00% | 17.16% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | A | Incentive Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 47,214 | 9999.99% | 100.00% |